Butyrylcholinesterase activity, cardiovascular risk factors, and mortality in middle-aged and elderly men and women in Jerusalem.
暂无分享,去创建一个
Joseph H Abramson | J. Kark | R. Calderon-Margalit | Ronit Calderon-Margalit | Jeremy D Kark | Bella Adler | Jaime Gofin | J. Abramson | J. Gofin | B. Adler
[1] L. H. Easson,et al. Choline-esterase. An enzyme present in the blood-serum of the horse. , 1932, The Biochemical journal.
[2] J. C. Torre,et al. Alzheimer Disease as a Vascular Disorder: Nosological Evidence , 2002 .
[3] Daniel W. Jones,et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.
[4] G. Picheth,et al. Butyrylcholinesterase activity and risk factors for coronary artery disease , 2002, Scandinavian journal of clinical and laboratory investigation.
[5] A. Brock,et al. Plasma cholinesterase activity in a healthy population group with no occupational exposure to known cholinesterase inhibitors: relative influence of some factors related to normal inter- and intra-individual variations. , 1990, Scandinavian journal of clinical and laboratory investigation.
[6] R. Heine,et al. Is pseudocholinesterase activity related to markers of triacylglycerol synthesis in Type II diabetes mellitus? , 2001, Clinical science.
[7] M. Maekawa,et al. Genetic mutations of butyrylcholine esterase identified from phenotypic abnormalities in Japan. , 1997, Clinical chemistry.
[8] D. Royall,et al. Alzheimer disease as a vascular disorder: nosological evidence. , 2002, Stroke.
[9] Y. Sako,et al. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. , 1987, Journal of chromatography.
[10] M. Mathews,et al. Relationship between serum butyrylcholinesterase and the metabolic syndrome. , 2005, Clinical biochemistry.
[11] T. Hansen,et al. Large-scale studies of the functional K variant of the butyrylcholinesterase gene in relation to Type 2 diabetes and insulin secretion , 2004, Diabetologia.
[12] M. Luca,et al. Serum cholesterol levels modulate long-term efficacy of cholinesterase inhibitors in Alzheimer disease , 2003, Neuroscience Letters.
[13] J. Kark,et al. Trends in blood pressure levels over time in middle-aged and elderly Jerusalem residents. , 1995, European heart journal.
[14] C. Geula,et al. Neurobiology of butyrylcholinesterase , 2003, Nature Reviews Neuroscience.
[15] R. R. Holman,et al. Butyrylcholinesterase K variant on chromosome 3 q is associated with Type II diabetes in white Caucasian subjects , 2001, Diabetologia.
[16] M. Knedel,et al. Eine kinetische Methode zur Bestimmung der Aktivität der Pseudocholinesterase (Acylcholin-acylhydrolase 3.1.1.8.) , 1967, Klinische Wochenschrift.
[17] A. Dietz,et al. Correlation of Cholinesterase with Serum Lipids and Lipoproteins , 1987, Journal of clinical pharmacology.
[18] M. O’Malley,et al. Standardization of Clinical Cholinesterase Measurements , 2002, International journal of toxicology.
[19] I. Rosenberg,et al. Nonfasting Plasma Total Homocysteine Level and Mortality in Middle-Aged and Elderly Men and Women in Jerusalem , 1999, Annals of Internal Medicine.
[20] R. Gofin,et al. Risk markers for mortality among elderly men-a community study in Jerusalem. , 1982, Journal of chronic diseases.
[21] A. Beynen,et al. Dietary cholesterol lowers the activity of butyrylcholinesterase (EC 3.1.1.8), but elevates that of esterase-1 (EC 3.1.1.1) in plasma of rats , 1993, British Journal of Nutrition.
[22] L. Kricka,et al. Effects of Storage and Repeated Freezing and Thawing on Plasma Cholinesterase Activity , 1984, Annals of clinical biochemistry.
[23] J. Kark,et al. The prevalence of obesity and its changes over time in middle-aged and elderly men and women in Jerusalem. , 1996, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.
[24] J. Santerre,et al. Mutual influence of cholesterol esterase and pseudocholinesterase on the biodegradation of dental composites. , 2004, Biomaterials.
[25] J. L. Smith,et al. Monographs in Human Genetics , 1972 .
[26] Z. Janka,et al. Increased serum butyrylcholinesterase activity in type IIb hyperlipidaemic patients. , 2004, Life sciences.
[27] D. R. Davies,et al. A Relationship between Body Fat and Plasma Pseudo-Cholinesterase , 1954, British Journal of Nutrition.
[28] P. Masson. A naturally occurring molecular form of human plasma cholinesterase is an albumin conjugate. , 1989, Biochimica et biophysica acta.